Pathology-supported genetic testing directed at shared disease pathways for optimized health in later life

Personalized Medicine

Volumn 10, Issue 5, 2013, Pages 497-507

  Kotze, Maritha J ^a   Van Velden, David P ^a   Botha, Karien ^b   Badenhorst, Casper H ^c   Avenant, Heloise ^d   Van Rensburg, Susan J ^a   Cronjé, Frans J ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b Paarl Medical Centre   (South Africa)

^c Integrated Health   (South Africa)

^d Blueprint Health (Pty) Ltd   (South Africa)

Author keywords

database; genomics; nutrigenetics; nutrigenomics; pathology; pharmacogenetics; pharmacogenomics; screen; wellness

Indexed keywords

CYTOCHROME P450 2D6; FLUROTHYL;

ARTICLE; CANCER GENETICS; CANCER PATIENT; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; EXOME; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOMICS; GLUCOSE INTOLERANCE; HEMOCHROMATOSIS; LIFESTYLE; METABOLIC SYNDROME X; NEEDS ASSESSMENT; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; VALIDATION STUDY; WORKSHOP;

EID: 84880214764     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.43     Document Type: Article

References (32)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431(7011), 931-945 (2004
2. Hodgson J. South Africa seeks genomic partners. Nat. Biotechnol. 19, 601-602 (2001
3. Kotze MJ. Application of molecular genetics in clinical practice. S. Afr. Fam. Pract. 47(1), 3 (2005
4. Kotze MJ, de Villiers JN, van der Merwe SJ. Preventing organ damage by genetic testing for hereditary haemochromatosis. S. Afr. Fam. Pract. 47(2), 44-45 (2005
5. Kotze MJ, Badenhorst H. Chronic disease risk management: Combining genetic testing with medical and nutrition therapy. S. Afr. Fam. Pract. 47(4), 40-42 (2005
6. Kotze MJ, la Grange C, Mansvelt EP. Rapid thrombophilia genetic test facilitates improved prenatal care for mother and child. S. Afr. Fam. Pract. 47(7), 50-51 (2005
7. Kotze MJ, Malan J, Pienaar R, Apffelstaedt J. The role of molecular genetic testing in modern breast health management. S. Afr. Fam. Pract. 47(9), 38-40 (2005
8. Kotze MJ, Thiart R, Hugo FJ, Potocnik FC. Cardiovascular genetic assessment and treatment in middle age to reduce the risk of heart disease and dementia in old age. S. Afr. Fam. Pract. 48(4), 53-54 (2006
9. Berdasco M, Esteller M. Genetic syndromes caused by mutations in epigenetic genes. Hum. Genet. 132(4), 359-383 (2013
10. van Velden DP, van der Merwe S, Fourie E, Kidd M, Blackhurst DM, Kotze MJ, Mansvelt EP. The acute influence of a Mediterranean-like diet with and without red wine on patients with the metabolic syndrome. S. Afr. J. Enol. Vitic. 28, 44-49 (2007
11. Pepe C, Guidugli L, Sensi E et al. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers. Breast Cancer Res. Treat. 103(1), 29-36 (2006
12. Goldsmith L, Jackson L, O'Connor A, Skirton H. Direct-to-consumer genomic testing from the perspective of the health professional: A systematic review of the literature. J. Community Genet. 4(2), 169-180 (2013
13. EW Chua, MA Kennedy. Current state and future prospects of direct-to-consumer pharmacogenetics. Front. Pharmacol. 3, 152 (2012
14. Kotze MJ, van Rensburg SJ. Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease. Metab. Brain Dis. 27(3), 255-266 (2012
15. Kotze MJ, Kriegshäuser G, Thiart R et al. Simultaneous detection of multiple familial hypercholesterolaemia mutations facilitates an improved diagnostic service in South African patients at high risk of cardiovascular disease. Mol. Diagn. 7(3-4), 169-174 (2003
16. Vergotine J, Thiart R, Scholtz CL, Kotze MJ. Clinical versus molecular diagnosis of heterozygous familial hypercholesterolaemia in the South African population. S. Afr. Med. J. 91, 1053-1059 (2001
17. Marais AD, Firth JC, Blom DJ. Familial hypercholesterolemia in South Africa. Sem. Vasc. Med. 4, 93-95 (2004
18. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: Lack of evidence for MTHFR polymorphism testing. Genet. Med. 15(2), 153-156 (2013
19. Kennedy DA, Stern SJ, Matok I et al. Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: A systematic review and meta-analysis. J. Cancer Epidemiol. 2012, 952508 (2012
20. Papakostas GI, Cassiello CF, Iovieno N. Folates and S-adenosylmethionine for major depressive disorder. Can. J. Psychiatry 57(7), 406-413 (2012
21. van der Merwe N, Bouwens CS, Pienaar R et al. CYP2D6 genotyping and use of antidepressants in breast cancer patients: Test development for clinical application. Metab. Brain Dis. 27(3), 319-326 (2012
22. van Rensburg SJ, Kotze MJ, van Toorn R. The conundrum of iron in multiple sclerosis - time for an individualised approach. Metab. Brain Dis. 27(3), 239-253 (2012
23. Kotze MJ, van Velden D, van Rensburg SJ, Erasmus R. Pathogenic mechanisms underlying iron deficiency and iron overload: New insights for clinical application. J. Int. Fed. Clin. Chem. Lab. Med. eJIFCC-02-01, 1-15 (2009
24. Kotze MJ, de Villiers JN, Bouwens CS et al. Molecular diagnosis of hereditary haemochromatosis: Application of a newly-developed reverse-hybridisation assay in the South African population. Clin. Genet. 65(4), 317-321 (2003
25. Vogel S, Geiger D, Avenant H, Kotze MJ. A questionnaire-based survey to rate doctors' opinions on genetic testing in the era of personalised medicine. Presented at: Joint International Congress of the African and Southern African Societies of Human Genetics. Cape Town, South Africa, 6-9 March 2011
26. Idemyor V. Genomic Medicine: Health care issues and the unresolved ethical and social dilemmas. Am. J. Ther. doi:10.1097/ MJT.0b013e3182583bd1 (2012) (Epub ahead of print
27. Kotze MJ, Schorn D, Coetzer P. The impact of genetic testing on life insurance. J. Genomics Afr. Soc. 1(1), 1-11 (2004
28. Raeburn S. Implications of genetic testing for the insurance industry: The UK example. Community Genet. 5(2), 102-109 (2002
29. Phillips KA, Veenstra DL, Ramsey SD, van Bebber SL, Sakowski J. Genetic testing and pharmacogenomics: Issues for determining the impact to healthcare delivery and costs. Am. J. Manag. Care 10(7), 425-432 (2004
30. van Velden DP, Kotze MJ, Blackhurst D, Marnewick J, Kidd M. Health claims on the benefits of moderate alcohol consumption in relation to genetic profiles. J. Wine Res. 22, 123-129 (2011
31. Grant K, JP Apffelstaedt JA, Wright C et al. MammaPrint® Prescreen Algorithm (MPA) reduces chemotherapy in South African breast cancer patients. Breast 22 (Suppl. 1), S92 (2013
32. Kotze MJ. Disease profiles in the genetically distinct populations of South Africa. Presented at: International Congress of Human Genetics. Vienna, Austria, 16 May 2001